‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease

BOSTON — The executives behind Altos Labs would really, really like people to stop saying they’re trying to reverse aging.

They have a couple things going against them on this count. For one, the first article about the biotech and its $3 billion stash talked about Silicon Valley billionaires “living forever.” And then there’s their most prominent scientist’s tendency to talk openly about people living to 130.

And yet at the STAT Summit on Tuesday, CEO Hal Barron and Juan Carlos Izpisua Belmonte, who leads the San Diego division of Altos Institutes of Science, offered an eloquent defense of the company, even if sometimes they couldn’t help but sound sometimes like a longevity company.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In